Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
This is the complete answer, not a partial one — the list is never padded.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Kristen Fortney | $600,000 | $0 | $0 | $1,941,390 | $330,000 | $0 | $15,200 | $2,886,590 |
| Chief Executive Officer and President | ||||||||
| Paul Rubin | 520,200 | 0 | 0 | 732,600 | 208,080 | 0 | 15,200 | 1,476,080 |
| Chief Medical Officer | ||||||||
| Eric Morgen | 499,600 | 0 | 0 | 732,600 | 199,840 | 0 | 15,200 | 1,447,240 |
| Chief Operating Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Kristen Fortney | $2,886,590 | — | — | — |
| Paul Rubin | 1,476,080 | — | — | — |
| Eric Morgen | 1,447,240 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
No insider equity transactions reported since the proxy statement.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Kristen Fortney | Option | 7,229 | 7.23 | — |
| Kristen Fortney | Option | 36,141 | 10.85 | — |
| Kristen Fortney | Option | 413,026 | 8.39 | — |
| Kristen Fortney | Option | 292,069 | 18 | — |
| Kristen Fortney | Option | 408,542 | 4.38 | — |
| Eric Morgen | Option | 2,680 | 6.57 | — |
| Eric Morgen | Option | 13,396 | 10.85 | — |
| Eric Morgen | Option | 150,485 | 8.39 | — |
| Eric Morgen | Option | 154,167 | 4.38 | — |
| Paul Rubin | Option | 1,712 | 6.57 | — |
| Paul Rubin | Option | 8,558 | 10.85 | — |
| Paul Rubin | Option | 102,637 | 8.39 | — |
| Paul Rubin | Option | 154,167 | 4.38 | — |
Base salary is the only fixed component of our named executive officers’ total cash compensation and provides competitive and stable pay to attract and retain our executives.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Alpine Rewards LLC |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | — |
| Annual cash retainer | $40,000 |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 15,000 / 40,000 / 10,000 |
| Stock ownership guideline | — |
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | BioAge Labs | 2025 | Kristen Fortney | $600,000 | $0 | $1,941,390 | $330,000 | $2,886,590 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Kristen Fortney | DEF 14A | 2026-04-21 | 0001193125-26-166738 | Section “Executive Compensation”. As printed: 2,886,590. Filing ↗machine: r2 · c19 · span 428555–428564 |
| 2 | Section 01, Paul Rubin | DEF 14A | 2026-04-21 | 0001193125-26-166738 | Section “Executive Compensation”. As printed: 1,476,080. Filing ↗machine: r6 · c19 · span 459062–459071 |
| 3 | Section 01, Eric Morgen | DEF 14A | 2026-04-21 | 0001193125-26-166738 | Section “Executive Compensation”. As printed: 1,447,240. Filing ↗machine: r4 · c19 · span 443811–443820 |
| 4 | BioAge Labs (subject), Section 10b CEO total | DEF 14A | 2026-04-21 | 0001193125-26-166738 | CEO total compensation as printed in BioAge Labs's own proxy. As printed: 2,886,590. Filing ↗machine: r2 · c19 · span 428555–428564 |